Repligen RGEN Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue (Gross) by Product | ||||||
| Royalty | $44K+25.7% | $185K+20.9% | $39K+5.4% | $37K+5.7% | $35K-2.8% | |
| Concentration Risk % by Geography | ||||||
| Asia Pacific And Rest Of World | 17%+2.0pp | —— | —— | —— | 15%+11.0pp | |
| Europe | 37%+2.0pp | 1%— | 30%-3.0pp | 38%0.0pp | 35%+2.0pp | |
| North America | 46%-4.0pp | —— | 51%0.0pp | 49%0.0pp | 50%+1.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Repligen break its business down?
- Repligen (RGEN) reports revenue (gross) by product across 3 parts — Process Analytics Products, Proteins Products and Royalty. Each is extracted from the segment footnotes and tracked over time.
- Where does Repligen's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Repligen's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
